Aviation Company Soars 28%

Good Afternoon! 

Hey, everyone. It's Adam from Elite Trade Club. 

Here’s what moved the market today.

Markets 📈

U.S. indexes remained somewhat steady today, without major swings in either direction. The Dow Jones managed to edge slightly ahead, adding 0.09% to yesterday’s total.

Top Stock Picks for 2024

7 Rare Buying Opportunities You Don’t Want to Miss

Eric Fry has a proven track record with 41 stock picks that soared over 1,000%, and another 20 that gained more than 500%. His expertise speaks for itself.

Now, he’s revealing 7 companies he expects to win big in 2024, and this is your chance to get in early before these stocks potentially take off.

These companies are positioned for massive growth in key industries, and missing out could mean leaving significant gains on the table.

The full research is available in a brand-new report, and the best part? It's completely free.

Download the free report now and uncover these high-potential stocks.

Market-Moving News 📈

Humana Deals with Dramatic Drop in Medicare Advantage Star Ratings

Humana experienced a nearly 15% drop in premarket trading on Wednesday following the announcement of a significant decline in its Medicare Advantage (MA) enrollment for plans rated four stars and above. According to preliminary data for the 2025 MA Star Ratings, only about 1.6 million members are enrolled in these higher-rated plans, reflecting a staggering 94% decrease compared to 2024 figures.

The Centers for Medicare and Medicaid Services (CMS) uses the Star Ratings system to reward plans with four or more stars with annual bonuses. Humana contested the accuracy of the reported ratings, suggesting potential errors in the CMS's calculations. In a regulatory filing, the company noted that its ratings were negatively impacted by narrowly missing higher industry thresholds on a few measures.

Humana is actively engaging with CMS to rectify any discrepancies in the data. While the company is committed to restoring its top-tier Star Ratings and improving its bonus payments for 2027, it has acknowledged the potential revenue challenges for 2026 stemming from the current ratings decline. Despite this setback, Humana emphasized that the 2025 ratings will not significantly affect its financial outlook for 2024 and 2025.

Eli Lilly Expands U.S. Operations with $4.5 Billion Indiana Facility

Eli Lilly has announced plans to invest $4.5 billion to establish a new center for advanced manufacturing and drug development in Indiana. The new facility, known as the Lilly Medicine Foundry, will focus on improving the production of medicines and scaling up drug manufacturing for clinical trials. By leveraging innovative research methods, the company aims to increase output and speed up the delivery of treatments to patients.

Set to be located in Lebanon, Indiana, the facility is expected to open by late 2027. Once fully operational, it will create 400 full-time jobs, including roles for engineers, scientists, and lab technicians. This investment marks a major step forward for Lilly's presence in Indiana and builds on the company's earlier commitments in the region.

Previously, Eli Lilly committed $5.3 billion toward manufacturing active pharmaceutical ingredients for its diabetes and obesity treatments in Lebanon. With this latest investment, Lilly’s total capital commitment in the U.S. since 2020 will exceed $23 billion, highlighting the company’s focus on expanding its domestic production capabilities. This new facility will not only enhance manufacturing efficiency but also play a crucial role in supporting the development of new treatments for patients worldwide.

Leadership Shift Sparks Strategic Changes at Nike

Nike has decided to withdraw its full-year forecast and delay its investor meeting as it prepares for a change in leadership. With a new CEO set to take over this month, the company aims to provide quarterly updates moving forward. This shift is expected to give the incoming leader, a longtime Nike executive, flexibility in addressing current strategies and shaping future plans.

Recent results indicate that Nike has adjusted its revenue expectations downward, influenced by weaker sales across its digital platforms and traditional retail channels. The company also reported a decline in wholesale revenue and acknowledged the need to strengthen relationships with retailers. Nike's direct-to-consumer strategy, which had boosted sales during the pandemic, is now facing challenges as consumer preferences shift.

Sales for the company's legacy products, including popular sneaker lines, have also slowed. Nike plans to refresh its product offerings and focus on innovation to regain market momentum. However, analysts remain cautious as overall demand in the sneaker industry softens, and Nike works to stabilize its market position amid shifting trends.

Technology

Emerging AI Leader Set for Explosive Growth

This rapidly expanding AI startup has generated 3.5X ROI for Fortune 1000 clients and is backed by key investors from top tech firms.

Its valuation has surged from $5M to $85M in just 3 years, doubling revenue while revolutionizing the marketing space.

With shares available at just $0.50, this is a rare opportunity for early investors to get in on the ground floor.

Secure your position now and be part of this AI-driven revolution.

Joby Aviation [JOBY] $6.14 (+27.92%)

Joby Aviation received an additional $500 million in funding from Toyota today, bringing the auto manufacturer’s investment to just shy of $1 billion.

ModivCare Inc [MODV] $17.64 (+21.82%)

ModivCare made changes to its credit agreement with JPMorgan Chase Bank, boosting net leverage and allowing the company to collect delayed contact receivables.

Novavax Inc [NVAX] $14.68 (+19.16%)

Novavax is looking solid as analysts believe it’s in good position to meet 2024 revenue guidance.

Sobr Safe Inc [SOBR] $6.40 (-13.16%)

Sobr Safe is dealing with the ramifications of a reverse stock split it initiated at the start of the week.

Humana Inc [HUM] $246.49 (-11.79%)

Humana shares tank today as the insurance company’s Medicare plan ratings suffer.

Conagra Brands [CAG] $30.08 (-8.07%)

Conagra Brands shared lackluster earnings in its Q4 report, causing its stock to fall.

Profit-Driven Trade

A Rare Opportunity for Potential Massive Gains

There’s a unique opportunity on the horizon with the chance to achieve significant returns.

A proven trade has been designed to capture stock movements before they even happen, helping turn even small price shifts into potentially big wins.

This method simplifies trading with straightforward, actionable instructions—taking advantage of market moves quickly and efficiently.

The potential here could lead to significant returns in a short amount of time.

Don’t miss out on the chance to be part of this—get the full details now.

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.